| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief R&D Strategy Officer | Chief Scientific Officer
1 company
Liu David Y is a Chief R&D Strategy Officer at Protagonist Therapeutics, Inc. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $10.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 3,500 | $15.00 | $52,500.00 | -63.6% | |
| Jul 10, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Scientific Officer | Sale+OE | 3,500 | $12.68 | $44,380.00 | -63.6% |